rs13028359

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000449086.5(LINC00954):​n.921-856A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 152,182 control chromosomes in the GnomAD database, including 7,379 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7379 hom., cov: 33)

Consequence

LINC00954
ENST00000449086.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0470

Publications

6 publications found
Variant links:
Genes affected
LINC00954 (HGNC:48668): (long intergenic non-protein coding RNA 954)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000449086.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.374 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000449086.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00954
NR_033875.1
n.941-856A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00954
ENST00000449086.5
TSL:1
n.921-856A>G
intron
N/A
LINC00954
ENST00000649549.1
n.579-731A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.291
AC:
44325
AN:
152064
Hom.:
7381
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.144
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.324
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.0899
Gnomad SAS
AF:
0.186
Gnomad FIN
AF:
0.370
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.378
Gnomad OTH
AF:
0.302
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.291
AC:
44319
AN:
152182
Hom.:
7379
Cov.:
33
AF XY:
0.286
AC XY:
21260
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.144
AC:
5973
AN:
41526
American (AMR)
AF:
0.323
AC:
4944
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1410
AN:
3468
East Asian (EAS)
AF:
0.0897
AC:
464
AN:
5172
South Asian (SAS)
AF:
0.188
AC:
907
AN:
4834
European-Finnish (FIN)
AF:
0.370
AC:
3923
AN:
10590
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.378
AC:
25667
AN:
67976
Other (OTH)
AF:
0.298
AC:
629
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1575
3150
4725
6300
7875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.349
Hom.:
8795
Bravo
AF:
0.285
Asia WGS
AF:
0.128
AC:
448
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
4.4
DANN
Benign
0.70
PhyloP100
0.047

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs13028359;
hg19: chr2-20078141;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.